AAAAAA

   
Results: 1-13 |
Results: 13
Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 subtypes A through J
Authors: Fontaine, E Riva, C Peeters, M Schmit, JC Delaporte, E Van Laethem, K Van Vaerenbergh, K Snoeck, J Van Wijngaerden, E De Clercq, E Van Ranst, M Vandamme, AM
Citation: E. Fontaine et al., Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 subtypes A through J, J ACQ IMM D, 28(3), 2001, pp. 254-258
Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype
Authors: Van Laethem, K Witvrouw, M Pannecouque, C Van Remoortel, B Schmit, JC Esnouf, R Kleim, JP Balzarini, J Desmyter, J De Clercq, E Vandamme, AM
Citation: K. Van Laethem et al., Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype, AIDS, 15(5), 2001, pp. 553-561
Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138
Authors: Pelemans, H Aertsen, A Van Laethem, K Vandamme, AM De Clercq, E Perez-Perez, MJ San-Felix, A Velazquez, S Camarasa, MJ Balzarini, J
Citation: H. Pelemans et al., Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138, VIROLOGY, 280(1), 2001, pp. 97-106
Presence of 2 ',5 '-bis-O-(tert-butyldimethylsilyl)-3 '-spiro-5 ''-(4 ''-amino-1 '',2 ''-oxathiole-2 '',2 ''-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients
Authors: Van Laethem, K Schmit, JC Pelemans, H Balzarini, J Witvrouw, M Perez-Perez, MJ Camarasa, MJ Esnouf, RM Aquaro, S Cenci, A Perno, CF Hermans, P Sprecher, S Ruiz, L Clotet, B Van Wijngaerden, E Van Ranst, M Desmyter, J De Clercq, E Vandamme, AM
Citation: K. Van Laethem et al., Presence of 2 ',5 '-bis-O-(tert-butyldimethylsilyl)-3 '-spiro-5 ''-(4 ''-amino-1 '',2 ''-oxathiole-2 '',2 ''-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients, AIDS RES H, 16(9), 2000, pp. 825-833
Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy
Authors: Van Vaerenbergh, K Van Laethem, K Van Wijngaerden, E Schmit, JC Schneider, F Ruiz, L Clotet, B Verhofstede, C Van Wanzeele, F Muyldermans, G Simons, P Stuyver, L Hermans, P Evans, C De Clercq, E Desmyter, J Vandamme, AM
Citation: K. Van Vaerenbergh et al., Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy, AIDS RES H, 16(6), 2000, pp. 529-537
Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir
Authors: Van Laethem, K Witvrouw, M Balzarini, J Schmit, JC Sprecher, S Hermans, P Leal, M Harrer, T Ruiz, L Clotet, B Van Ranst, M Desmyter, J De Clercq, E Vandamme, AM
Citation: K. Van Laethem et al., Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir, AIDS, 14(4), 2000, pp. 469-471
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues
Authors: Van Vaerenbergh, K Van Laethem, K Albert, J Boucher, CAB Clotet, B Floridia, M Gerstoft, J Hejdeman, B Nielsen, C Pannecouque, C Perrin, L Pirillo, MF Ruiz, L Schmit, JC Schneider, F Schoolmeester, A Schuurman, R Stellbrink, HJ Stuyver, L Van Lunzen, J Van Remoortel, B Van Wijngaerden, E Vella, S Witvrouw, M Yerly, S De Clercq, E Desmyter, J Vandamme, AM
Citation: K. Van Vaerenbergh et al., Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues, ANTIM AG CH, 44(8), 2000, pp. 2109-2117
Evaluating clinical isolates for their phenotypic and genotypic resistanceagainst anti-HIV drugs
Authors: Vandamme, AM Witvrouw, M Pannecouque, C Balzarini, J Van Laethem, K Schmit, JC Desmyter, J De Clercq, E
Citation: Am. Vandamme et al., Evaluating clinical isolates for their phenotypic and genotypic resistanceagainst anti-HIV drugs, METH MOL M, 24, 2000, pp. 223-258
Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations
Authors: Van Laethem, K Van Vaerenbergh, K Schmit, JC Sprecher, S Hermans, P De Vroey, V Schuurman, R Harrer, T Witvrouw, M Van Wijngaerden, E Stuyver, L Van Ranst, M Desmyter, J De Clercq, E Vandamme, AM
Citation: K. Van Laethem et al., Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations, J ACQ IMM D, 22(2), 1999, pp. 107-118
Full-length genomic sequence of an HIV type 1 subtype G from Kinshasa
Authors: Oelrichs, RB Vandamme, AM Van Laethem, K Debyser, Z McCutchan, FE Deacon, NJ
Citation: Rb. Oelrichs et al., Full-length genomic sequence of an HIV type 1 subtype G from Kinshasa, AIDS RES H, 15(6), 1999, pp. 585-589
Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV
Authors: Witvrouw, M Pannecouque, C Van Laethem, K Desmyter, J De Clercq, E Vandamme, AM
Citation: M. Witvrouw et al., Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV, AIDS, 13(12), 1999, pp. 1477-1483
Long-term stability of human immunodeficiency virus viral load and infectivity in whole blood
Authors: Vandamme, AM Van Laethem, K Schmit, JC Van Wijngaerden, E Reynders, M Debyser, Z Witvrouw, M Van Ranst, M De Clercq, E Desmyter, J
Citation: Am. Vandamme et al., Long-term stability of human immunodeficiency virus viral load and infectivity in whole blood, EUR J CL IN, 29(5), 1999, pp. 445-452
Managing resistance to anti-HIV drugs - An important consideration for effective disease management
Authors: Vandamme, AM Van Laethem, K De Clercq, E
Citation: Am. Vandamme et al., Managing resistance to anti-HIV drugs - An important consideration for effective disease management, DRUGS, 57(3), 1999, pp. 337-361
Risultati: 1-13 |